

Management



Evaluations Following Initial Diagnosis

 To establish the extent of disease in an individual diagnosed with spinocerebellar ataxia type 12, the following evaluations are recommended: Medical history Tremor rating and gait ataxia assessment Evaluation for peripheral neuropathy and autonomic dysfunction Radiologic investigation to evaluate for associated brain structural damage which can influence the disease course

Treatment of Manifestations

 Symptomatic treatment including the following may be of great value: Pharmacologic agents, including beta-blockers, clonazepam and phenobarbital derivatives, and benzodiazepines to decrease tremor amplitude. Modest success has been observed in some affected individuals. Supplements of antioxidants, which may have some beneficial effects. However, their effect on disease outcome has not been validated through clinical trials. Treatment of psychiatric syndromes as needed Physical therapy to help maintain strength, flexibility, and independent mobility Technical assistance with writing and other fine-motor tasks

Prevention of Secondary Complications

 A safe home environment can minimize the risk of injury from falls.

Surveillance

 Annual reevaluation may be helpful for disability assessment and identification of comorbidities.

Evaluation of Relatives at Risk

 See Genetic Counseling for issues related to testing of at-risk relatives for genetic counseling purposes.

Therapies Under Investigation

 Search ClinicalTrials.gov for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.

Other

 Recommended: Education of affected individuals and their families Neuroimaging studies as appropriate to exclude the presence of other lesions, particularly after falls